Patent · US Active

Use of electric field gradients to control gene expression

US12172159B2 · kind B2 · utility

0Cited by
2References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 23, 2020
Grant dateDec 24, 2024
Priority date
Expiry dateOct 26, 2043

Classification

  • Technology area (CPC B)Performing Operations; Transporting
  • CPC primaryB01L2400/0424
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Methods of controlling biological processes by altering the electric field gradient in a test chamber are disclosed. A portion of a surface of the test chamber is attached to at least one immobilized component of the biological process. Microfluidic devices capable of same are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.